510(k) Report

510(k) · Cleared

Cleared

ReDs Wearable System

K150095510(k) TraditionalCleared Aug 6, 2015202-day reviewClass II21 CFR 870.2770

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sensible Medical Innovations, Ltd. · DSB Plethysmograph, Impedance

Cleared on Aug 6, 2015 as substantially equivalent to K131509 (Noninvasive Medical Technologies, Inc., 2013) and 5 other predicates after a 202-day review. Its family tree reaches back 5 generations to 2000. 1 later device descends from it.

Decided
Aug 6, 2015
Review
202 days
Class
Class II
Product code
DSB
Recalls
None
Predicates
6

Its longest line of descent runs back 5 generations to K000126 (2000). 12 ancestors in all, the oldest K922218 (1992). 1 later device descends from it, 1 citing it directly.

  1. Root · 5 generations backK000126 Masimo Set Radical Pulse Oximeter with Satshare, Masimo…Masimo Corp. · 2000
  2. 4 generations backK031330 Modification to Masimo Set Radical Pulse Oximeter with Satshare and…Masimo Corp. · 2003
  3. 3 generations backK033296 Masimo Set Rad-5 Pulse Oximeter, Model Rad-5; Masimo Set Rad-5V…Masimo Corp. · 2004 · Recalled
  4. 2 generations backK070985 Aesculon CHF, Hypertension & Pacemaker ClinicOsypka Medical, Inc. · 2008
  5. 1 generation backK081035 Aesculon C2, Aesculon CHF Clinic C2, Aesculon Hypertension Clinic C2…Osypka Medical, Inc. · 2008
  6. This deviceK150095 ReDs Wearable SystemSensible Medical Innovations, Ltd. · 2015
  7. Descendant · cites it directly · 0 of its ownK180479 ReDS SystemSensible Medical Innovations, Ltd. · 2019

Most influential descendants

Showing 1 of 1 · See all
  • K180479ReDS SystemSensible Medical Innovations, Ltd. · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K000126Masimo Set Radical Pulse Oximeter with Satshare, Masimo…Masimo Corp.2000—
−4K031330Modification to Masimo Set Radical Pulse Oximeter with Satshare and Lnop…Masimo Corp.2003—
−3K033296Masimo Set Rad-5 Pulse Oximeter, Model Rad-5; Masimo Set Rad-5V Pulse…Masimo Corp.20041
−2K070985Aesculon CHF, Hypertension & Pacemaker ClinicOsypka Medical, Inc.2008—
−1K081035Aesculon C2, Aesculon CHF Clinic C2, Aesculon Hypertension Clinic C2 and…Osypka Medical, Inc.2008—
0 (this device)K150095ReDs Wearable SystemSensible Medical Innovations, Ltd.2015—
+1K180479ReDS SystemSensible Medical Innovations, Ltd.2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199910
200110
200410
201210
201310
201410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
FIG. 1 — Lineage of K150095, 2000–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSB device

  1. #1 K232089 SOZO Proscore 14.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (6)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K131509Zoe Fluid Status Monitor
Summary page 5
…K150095 Predicate Devices:  ZOE Fluid Status Monitor (NMT Medical), product code DSB, cleared for marketing under K131509, K112830, K042113, K133301 (primary predicate)  Aesculon (Osypka Medical), product code DSB, cleared for marketin…
Noninvasive Medical Technologies, Inc.2013—
*K112830Zoefluid Status Monitor (Model Zoe 2B)
Summary page 5
…K150095 Predicate Devices:  ZOE Fluid Status Monitor (NMT Medical), product code DSB, cleared for marketing under K131509, K112830, K042113, K133301 (primary predicate)  Aesculon (Osypka Medical), product code DSB, cleared for marketing…
Noninvasive Medical Technologies, Inc.2012—
*K042113Zoe Fluid Status Monitor
Summary page 5
…K150095 Predicate Devices:  ZOE Fluid Status Monitor (NMT Medical), product code DSB, cleared for marketing under K131509, K112830, K042113, K133301 (primary predicate)  Aesculon (Osypka Medical), product code DSB, cleared for marketing under K0…
Noninvasive Medical Technologies, LLC2004—
*K133301Zoe Fluid Status Monitor
Summary page 5
…K150095 Predicate Devices:  ZOE Fluid Status Monitor (NMT Medical), product code DSB, cleared for marketing under K131509, K112830, K042113, K133301 (primary predicate)  Aesculon (Osypka Medical), product code DSB, cleared for marketing under K070985, K0…
Noninvasive Medical Technologies, Inc.2014—
*K070985Aesculon CHF, Hypertension & Pacemaker Clinic
Summary page 5
…marketing under K131509, K112830, K042113, K133301 (primary predicate)  Aesculon (Osypka Medical), product code DSB, cleared for marketing under K070985, K081035 Indications for Use: ReDS is intended for use by qualified health care practitioners and by patients, under the direct…
Osypka Medical, Inc.2008—
*K081035Aesculon C2, Aesculon CHF Clinic C2, Aesculon Hypertension Clinic C2 and Aesculon…
Summary page 5
…g under K131509, K112830, K042113, K133301 (primary predicate)  Aesculon (Osypka Medical), product code DSB, cleared for marketing under K070985, K081035 Indications for Use: ReDS is intended for use by qualified health care practitioners and by patients, under the direction of a…
Osypka Medical, Inc.2008—

Also cleared against K131509: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K180479ReDS SystemSensible Medical Innovations, Ltd.20190

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 3 companies; a new generation was cleared every 3.1 years on median.
  • 1 of the 12 ancestors has a recall of any class.
  • Of its descendants, K180479 (Sensible Medical Innovations, Ltd., 2019) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K131509.

How does its category compare?

All DSB devices

DSB Plethysmograph, Impedance: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · DSB

3in 2025

2007: 22008: 62009: 22010: 12011: 22012: 12013: 22014: 22015: 22017: 22018: 12019: 12020: 22021: 12022: 12023: 22025: 32026 (partial year): 1
2007high 6 (2008) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSB

266in 2025

2008: 90 days median2025: 266 days median
2007high 266 (2025) · low 90 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSB

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSB

2in 2025

2016: 12025: 2
2007high 2 (2025) · low 0 (2007)2025

MAUDE reports naming product code DSB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
200869000
20092—00
20101—00
20112—00
20121—00
20132—00
20142—00
20152—10
20160—01
20172—00
20181—00
20191—00
20202—00
20211—00
20221—00
20232—00
20240—00
2025326602
20261—0—

What is it indicated for?

ReDS is intended for use by qualified health care practitioners and by patients, under the direction of a physician, in hospitals, hospital-type facilities and home environment, for the non-invasive monitoring and management of patients with fluid management problems in a variety of medically accepted clinical applications.

ReDS is indicated for patients:

With fluid management problems

Taking diuretic medication

Living with Heart Failure

Recovering from Coronary Artery Disease related event

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K150095: ReDs Wearable System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K150095

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026